Clemsza Tablet
Product Images NDC 71085-081

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clemsza (NDC 71085-081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ipg Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clemastine 1)

Chemical structure of Clemastine Fumarate, showing the molecular arrangement of atoms with a cyclopropylamine, phenyl groups, and fumaric acid components.*

FDA Label Image

Image Description (Image 081)

Label for CLEMSZA 2.68 mg tablets containing Clemastine Fumarate USP, manufactured by IPG Pharmaceuticals, Inc. The label includes dosage form (tablet), strength (2.68 mg), package count (30 tablets), and prescription status (Rx Only). It shows storage instructions, barcode, NDC 71085-081-30, and manufacturer contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.